Edition:
India

People: Entera Bio Ltd (ENTX.OQ)

ENTX.OQ on NASDAQ Stock Exchange Capital Market

2.43USD
13 Nov 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.43
Open
$2.43
Day's High
$2.43
Day's Low
$2.43
Volume
1,955
Avg. Vol
2,519
52-wk High
$6.29
52-wk Low
$1.60

Garceau, Roger 

Dr. Roger J. Garceau is Director of the company since March 2016 and as Chief Development Advisor since December 2016. Prior to joining Entera, Dr. Garceau served as Chief Medical Officer and Executive Vice President of NPS Pharmaceuticals, Inc. since December 2008 and January 2013 respectively, until February 2015, when NPS Pharmaceuticals was acquired by Shire plc. Previously, Dr. Garceau served in several managerial positions with NPS Pharmaceuticals, Inc. Sanofi-aventis and Pharmacia Corporation. Dr. Garceau has been a non-executive director of Enterome SA since December 2016. Dr. Garceau is a board-certified pediatrician and is a Fellow of the American Academy of Pediatrics. Dr. Garceau holds a B.S. in Biology from Fairfield University in Fairfield, Connecticut and an M.D. from the University of Massachusetts Medical School.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 886,925
Long-Term Incentive Plans, USD --
All Other, USD 114,000
Fiscal Year Total, USD 1,000,920

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --